1-20633732-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032409.3(PINK1):āc.184G>Cā(p.Gly62Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000326 in 1,534,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_032409.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PINK1 | NM_032409.3 | c.184G>C | p.Gly62Arg | missense_variant | 1/8 | ENST00000321556.5 | NP_115785.1 | |
MIR6084 | NR_106732.1 | n.54G>C | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINK1 | ENST00000321556.5 | c.184G>C | p.Gly62Arg | missense_variant | 1/8 | 1 | NM_032409.3 | ENSP00000364204 | P1 | |
MIR6084 | ENST00000622012.1 | n.54G>C | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 151952Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000383 AC: 5AN: 130606Hom.: 0 AF XY: 0.0000278 AC XY: 2AN XY: 71828
GnomAD4 exome AF: 0.0000174 AC: 24AN: 1382362Hom.: 0 Cov.: 31 AF XY: 0.0000147 AC XY: 10AN XY: 682362
GnomAD4 genome AF: 0.000171 AC: 26AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74334
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.184G>C (p.G62R) alteration is located in exon 1 (coding exon 1) of the PINK1 gene. This alteration results from a G to C substitution at nucleotide position 184, causing the glycine (G) at amino acid position 62 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive early-onset Parkinson disease 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 62 of the PINK1 protein (p.Gly62Arg). This variant is present in population databases (rs759968468, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with PINK1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at